ImmunoPrecise Antibodies (IPA) Short Interest Ratio & Short Volume $0.39 -0.05 (-10.97%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$0.37 -0.02 (-5.61%) As of 03/28/2025 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ImmunoPrecise Antibodies Short Interest DataImmunoPrecise Antibodies (IPA) has a short interest of 3.03 million shares, representing 14.01% of the float (the number of shares available for trading by the public). This marks a 38.36% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 2.07 million shares to cover all short positions.Current Short Interest3,030,000 sharesPrevious Short Interest2,190,000 sharesChange Vs. Previous Month+38.36%Dollar Volume Sold Short$1.17 millionShort Interest Ratio0.4 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares31,062,000 sharesFloat Size21,620,000 sharesShort Percent of Float14.01%Today's Trading Volume602,111 sharesAverage Trading Volume2,073,477 sharesToday's Volume Vs. Average29% Short Selling ImmunoPrecise Antibodies? Sign up to receive the latest short interest report for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIPA Short Interest Over TimeIPA Days to Cover Over TimeIPA Percentage of Float Shorted Over Time Remove Ads ImmunoPrecise Antibodies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20253,030,000 shares $1.17 million +38.4%14.0%0.4 $0.38 2/28/20252,190,000 shares $751,608.00 +343.4%10.9%0.3 $0.34 2/15/2025493,900 shares $208,327.02 +37.5%2.5%0.1 $0.42 1/31/2025359,300 shares $167,146.36 +895.3%1.8%0.1 $0.47 1/15/202536,100 shares $18,772.00 -65.2%0.2%0 $0.52 12/31/2024103,600 shares $42,652.12 -30.9%0.5%0.2 $0.41 12/15/2024150,000 shares $60,491.40 -47.0%0.7%0.3 $0.40 11/30/2024283,000 shares $107,540.00 -58.9%1.3%0.5 $0.38 11/15/2024688,800 shares $306,171.60 +3.4%3.2%1.3 $0.44 10/31/2024666,100 shares $317,729.70 +355.9%3.1%1.4 $0.48 Get the Latest News and Ratings for IPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE daily newsletter. 10/15/2024146,100 shares $83,277.00 -19.8%0.7%0.7 $0.57 9/30/2024182,200 shares $116,425.80 +65.9%0.8%1.1 $0.64 9/15/2024109,800 shares $73,566.00 -2.1%0.5%0.9 $0.67 8/31/2024112,100 shares $84,635.50 +16.1%0.5%1.3 $0.76 8/15/202496,600 shares $86,940.00 -4.1%0.5%1.1 $0.90 7/31/2024100,700 shares $79,452.30 -14.4%0.5%1.4 $0.79 7/15/2024117,700 shares $114,992.90 -15.7%0.6%1.6 $0.98 6/30/2024139,600 shares $140,996.00 -8.0%0.7%1.8 $1.01 6/15/2024151,700 shares $159,285.00 -7.8%0.7%1.7 $1.05 5/31/2024164,600 shares $184,352.00 -18.1%0.8%1.3 $1.12 5/15/2024201,000 shares $230,808.30 -35.5%0.9%0.4 $1.15 4/30/2024311,500 shares $392,490.00 -8.4%1.5%0.5 $1.26 4/15/2024340,000 shares $421,600.00 +6.9%1.6%0.6 $1.24 3/31/2024318,200 shares $483,664.00 -27.8%1.5%0.5 $1.52 3/15/2024440,700 shares $634,608.00 +1,290.2%2.0%0.8 $1.44 2/29/202431,700 shares $58,328.00 -37.6%0.2%0.1 $1.84 2/15/202450,800 shares $100,584.00 +232.0%0.2%0.4 $1.98 1/31/202415,300 shares $27,693.00 -38.3%0.1%0.1 $1.81 1/15/202424,800 shares $41,168.00 +31.2%0.1%0.2 $1.66 12/31/202318,900 shares $32,319.00 -34.8%0.1%0.2 $1.71 12/15/202329,000 shares $40,020.00 +2.1%0.1%0.3 $1.38 11/30/202328,400 shares $44,588.00 -2.1%0.1%0.3 $1.57 11/15/202329,000 shares $42,050.00 -38.3%0.1%0.4 $1.45 10/31/202347,000 shares $108,269.20 +99.2%0.2%0.7 $2.30 10/15/202323,600 shares $30,208.00 -48.3%0.1%0.4 $1.28 9/30/202345,600 shares $83,448.00 +2.9%0.2%1 $1.83 9/15/202344,300 shares $77,968.00 -2.0%0.2%1 $1.76 8/31/202345,200 shares $85,428.00 +52.2%0.2%1.1 $1.89 8/15/202329,700 shares $67,315.05 -24.0%0.1%0.8 $2.27 7/31/202339,100 shares $98,532.00 -22.6%0.2%0.5 $2.52Claim Your FREE Protection Guide (Ad)In the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code... And since then, "in the know" patriots have quietly used this same "Trump loophole" to shield their life savings from the economic chaos. But with Trump now forcefully bringing back millions of manufacturing jobs from Mexico, China, and the entire BRICS anti-dollar coalition...Click Here to Claim Your FREE Trump 100-Day Strategy Guide Now → 7/15/202350,500 shares $142,410.00 -3.6%0.2%0.6 $2.82 6/30/202352,400 shares $155,104.00 -46.0%0.2%0.6 $2.96 6/15/202397,000 shares $280,330.00 -1.2%0.4%1.1 $2.89 5/31/202398,200 shares $310,312.00 +0.3%0.4%1.1 $3.16 5/15/202397,900 shares $299,574.00 No Change0.4%1.1 $3.06 10/31/2022129,400 shares $643,118.00 -12.5%N/A8 $4.97 10/15/2022147,800 shares $691,704.00 +41.8%N/A9 $4.68 9/30/2022104,200 shares $415,758.00 +17.6%N/A6.4 $3.99 9/15/202288,600 shares $430,596.00 -19.3%N/A5.6 $4.86 8/31/2022109,800 shares $585,234.00 -29.8%N/A7.4 $5.33 8/15/2022156,400 shares $828,920.00 -16.4%1.0%9.7 $5.30 7/31/2022187,100 shares $791,433.00 -6.7%1.1%11.7 $4.23 7/15/2022200,600 shares $762,280.00 -9.1%1.2%12.7 $3.80 6/30/2022220,600 shares $838,280.00 -4.8%1.3%10.5 $3.80 6/15/2022231,700 shares $919,849.00 -3.8%1.4%9.2 $3.97 5/31/2022240,800 shares $1.38 million +6.2%1.5%8.1 $5.73 5/15/2022226,800 shares $1.01 million -22.1%1.4%7.4 $4.45 4/30/2022291,300 shares $1.62 million -0.2%1.8%8.5 $5.56 4/15/2022291,900 shares $1.67 million +3.4%1.8%7.8 $5.72 3/31/2022282,200 shares $1.45 million +2.2%N/A0 $5.14 3/15/2022276,200 shares $1.09 million +0.2%1.6%7.5 $3.95 2/28/2022275,600 shares $1.36 million -16.8%1.6%7.5 $4.93 2/15/2022331,400 shares $1.70 million +21.8%1.9%7 $5.13 1/31/2022272,000 shares $1.68 million +16.5%1.6%5.7 $6.18 1/15/2022233,500 shares $1.46 million -24.8%N/A0 $6.26 12/31/2021310,300 shares $1.66 million -12.4%1.8%6 $5.36 12/15/2021354,200 shares $1.91 million +11.2%2.1%5.6 $5.38 11/30/2021318,500 shares $1.91 million +8.9%1.9%4.5 $6.00 11/15/2021292,500 shares $1.78 million -15.0%1.7%3.5 $6.10 10/29/2021344,200 shares $2.26 million -24.2%2.0%2.9 $6.57 10/15/2021454,100 shares $2.99 million +1.3%2.6%2.1 $6.58 9/30/2021448,200 shares $2.79 million -18.3%2.6%0.2 $6.22 9/15/2021548,800 shares $3.62 million -3.1%3.2%0.2 $6.60 8/31/2021566,400 shares $4.18 million -17.1%3.3%0.2 $7.38 8/13/2021682,800 shares $4.81 million +6.9%4.0%0.3 $7.05 7/30/2021638,500 shares $4.20 million +467.6%3.7%0.3 $6.58 7/15/2021112,500 shares $619,875.00 -23.5%0.7%0.1 $5.51 6/30/2021147,000 shares $884,940.00 +18.2%0.9%2.5 $6.02 6/15/2021124,400 shares $931,756.00 -8.0%0.8%1.7 $7.49 5/28/2021135,200 shares $1.06 million +42.3%0.8%1.7 $7.82 5/14/202195,000 shares $712,500.00 +11.8%0.6%1.2 $7.50 4/30/202185,000 shares $878,900.00 +2.8%0.5%0.9 $10.34 4/15/202182,700 shares $904,738.00 +386.5%N/A0 $10.94 3/31/202117,000 shares $150,280.00 +27.8%0.1%0.1 $8.84 3/15/202113,300 shares $153,083.00 -19.9%0.1%0.1 $11.51 2/26/202116,600 shares $222,108.00 +238.8%0.1%0.2 $13.38 2/12/20214,900 shares $68,845.00 -58.5%0.0%0.1 $14.05 1/29/202111,800 shares $200,600.00 +1,375.0%0.1%0.2 $17.00 1/15/2021800 shares $11,992.00 No Change0.0%0 $14.99 IPA Short Interest - Frequently Asked Questions What is ImmunoPrecise Antibodies' current short interest? Short interest is the volume of ImmunoPrecise Antibodies shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 3,030,000 shares of IPA short. 14.01% of ImmunoPrecise Antibodies' shares are currently sold short. Learn More on ImmunoPrecise Antibodies' current short interest. Which institutional investors are shorting ImmunoPrecise Antibodies? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ImmunoPrecise Antibodies: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for ImmunoPrecise Antibodies? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.01% of ImmunoPrecise Antibodies' floating shares are currently sold short. Is ImmunoPrecise Antibodies' short interest increasing or decreasing? ImmunoPrecise Antibodies saw a increase in short interest in March. As of March 15th, there was short interest totaling 3,030,000 shares, an increase of 38.4% from the previous total of 2,190,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ImmunoPrecise Antibodies' float size? ImmunoPrecise Antibodies currently has issued a total of 31,062,000 shares. Some of ImmunoPrecise Antibodies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ImmunoPrecise Antibodies currently has a public float of 21,620,000 shares. How does ImmunoPrecise Antibodies' short interest compare to its competitors? 14.01% of ImmunoPrecise Antibodies' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ImmunoPrecise Antibodies: PDS Biotechnology Co. (11.40%), Kronos Bio, Inc. (1.91%), Virpax Pharmaceuticals, Inc. (1.86%), X4 Pharmaceuticals, Inc. (5.15%), Aadi Bioscience, Inc. (6.58%), Werewolf Therapeutics, Inc. (6.04%), Immix Biopharma, Inc. (2.24%), Century Therapeutics, Inc. (8.70%), Iterum Therapeutics plc (4.52%), Outlook Therapeutics, Inc. (19.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short ImmunoPrecise Antibodies stock? Short selling IPA is an investing strategy that aims to generate trading profit from ImmunoPrecise Antibodies as its price is falling. IPA shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ImmunoPrecise Antibodies? A short squeeze for ImmunoPrecise Antibodies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IPA, which in turn drives the price of the stock up even further. How often is ImmunoPrecise Antibodies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IPA, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies PDSB Short Squeeze KRON Short Squeeze VRPX Short Squeeze XFOR Short Squeeze AADI Short Squeeze HOWL Short Squeeze IMMX Short Squeeze IPSC Short Squeeze ITRM Short Squeeze OTLK Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IPA) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoPrecise Antibodies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmunoPrecise Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
